Nikolai Kraiouchkine

Statistics

Publications

Citations

190

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Nikolai Kraiouchkine is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, vaccinology, and viral vaccines.

Publications per year

2004–2020

Publications

Novel Rotavirus VP7 Typing Assay Using a One-Step Reverse Transcriptase PCR Protocol and Product Sequencing and Utility of the Assay for Epidemiological Studies and Strain Characterization, Including Serotype Subgroup Analysis

Daniel J. DiStefano, Nikolai Kraiouchkine, Laura Mallette et al. · Journal of Clinical Microbiology · 2005 · 73 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model

Leigh Zerboni, Stewart Hinchliffe, Marvin Sommer et al. · Virology · 2004 · 60 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability

Tamer A. Elwaie, Safinaz E. Abbas, Enayat Ibrahim Aly et al. · Journal of Medicinal Chemistry · 2020 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

T J Palker, Irina Kiseleva, Kimberly B. Johnston et al. · Virus Research · 2004 · 20 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

1–4 of 4